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Abstract
Background: Adipose stem cells have a strong potential for use in cell-based therapy, but the current
nucleofection technique, which relies on unknown buffers, prevents their use.
Results: We developed an optimal nucleofection formulation for human adipose stem cells by using a three-step
method that we had developed previously. This method was designed to determine the optimal formulation for
nucleofection that was capable of meeting or surpassing the established commercial buffer (Amaxa), in particular
for murine adipose stem cells. By using this same buffer, we determined that the same formulation yields optimal
transfection efficiency in human mesenchymal stem cells.
Conclusions: Our findings suggest that transfection efficiency in human stem cells can be boosted with proper
formulation.
Keywords: Electroporation, Formulation, Stem cells, Transfection, Cell therapy
Background
Cell-based therapies have great potential for the treat-
ment of genetic disorders as well as currently incurable
diseases. Stem cells, the most attractive candidate for
such therapy, have been tested in the treatment of leu-
kemias [1,2] and in the regrowth of damaged tissue [3].
Adipose-derived stem cells (ASCs) have recently been
isolated [4] and characterized [5]. ASCs are a relatively
abundant and easily isolated pluripotent cell line, which
makes them a promising candidate as a vehicle for stem
cell therapy [4,6,7]. ASCs can be modified to differenti-
ate into various cell lineages, including adipogenic,
chondrogenic, and osteogenic cell lines [8], as well as
into myoblasts and endothelial cells [5]. ASCs have also
demonstrated the ability to home to certain types of
tumors [9], which makes them a viable option for anti-
tumor cell therapy.
In a previous study, we developed a method for opti-
mizing formulations to aid in the delivery of plasmid
DNA in the process of nucleofection [10]. Although
nucleofection is an effective form of nonviral transfec-
tion for many types of stem cells [11], its therapeutic
use is limited by the availability of secret formulations
developed by the commercial vendor Amaxa, which
must be purchased directly from the vendor. Our
devised method offers a three-step plan for determining
an optimal transfection formulation generated from
known chemicals. The use of this formulation is more
economical and in many cases surpasses the formulation
developed by Amaxa. Notably, our method resulted in
the use of pluronic-block copolymers for the develop-
ment of an optimal nucleofection formulation for mur-
ine ASCs.
In this study, we applied the method we developed in
our previous study [10] and explored the optimal
nucleofection formulation for human ASCs (hASCs) and
human mesenchymal stem cells (hMSCs). This study
looks even further into members of the pluronic-block
copolymer family and their effect on transfection effi-
ciency in hASCs. * Correspondence: sli4@mdanderson.org
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Initial determination of optimal buffer, electroporation
program, and polymer
To determine the optimal nucleofection formulation for
increasing transfection efficiency of hASCs by using an
Amaxa nucleofection device, we decided to use known
cell transfection electroporation buffers as a starting
point. Following our optimized nucleofection method
developed previously [10], we initially chose two buffers:
OptiMEM and pulsing buffer. To determine the nucleo-
fection program that would yield the highest effective-
ness, we used the following seven programs, as outlined
in the Amaxa Nucleofector Optimization Protocol: A-
20, T-20, T-30, X-01, X-05, L-29, and D-23. The results
of this first step are displayed in Figure 1a. Although it
appears the optimal program is X-05, program X-01
plus OptiMEM buffer yields a comparable and more
consistent increase in transfection efficiency (Figure 1a),
which was selected for further transfection analysis.
After determining the optimal buffer and electropora-
tion program, we determined whether the addition of
any polymers would further increase the effectiveness of
transfection. We tested five different polymers, specifi-
cally LME1, LMV1, LMP8, LMP3, and LMA1, as out-
lined in the Methods section. Our results of step two,
displayed in Figure 1b, showed that both LMV1 and
LMP8 produced the strongest increase in transfection
efficiency and were significantly better than other poly-
mers (p < 0.05). LMP8 was selected for futher analysis
because it had a higher rate of transfection than LMV1
(though not significant) and is consistent with our find-
ings with murine ASCs [10].
Exploration of pluronic-block copolymers
We previously optimized the transfection buffer for
murine ASCs and found that pluronic-block copolymers
caused the strongest increase in transfection. There are
numerous types of pluronic-block copolymers that vary
in molecular weight and hydrophilic properties. LMP1,
which is hydrophobic, bears a smaller hydrophilic
region, has a much lower molecular weight, and pro-
duced a much stronger increase in transfection than
LMP8 did in murine ASCs. Different from murine
ASCs, LMP1 failed to increase the effectiveness of
Figure 1 First two steps in the selection of electroporation formulation for human adipose-derived stem cells (ASCs).E r r o rb a r s
expressed as mean × SEM (n = 3). *, indicating a significant difference was detected at p < 0.05. (a) Step 1 of buffer optimization. 1 × 10E6 cells
were used for each cell transfection in 100 μL indicated buffers and different programs with use of Amaxa nucleofector. (b) Step 2 of buffer
optimization. The key for polymer abbreviations is in the Methods section. Differentiation of each polymer was tested. None, optimum buffer
without addition of any polymer.
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increase in transfection efficiency with the use of LMP5,
which has a low molecular weight that is similar to that
of LMP1, is much more hydrophilic, and has a hydro-
phile-to-hydrophobe ratio that is similar to that of
LMP8 (Figure 2).
To increase the fidelity of our discovery, each polymer
was repeatedly tested. Unlike other members of the
pluronic-block copolymer family, which consistently fail
to increase transfection efficiency, LMP5 efficiency per-
sistently trended higher than that of Buffer O alone
(Figure 3).
Observation of ASCs under scanning electron microscopy
DNA or cell formulations are generally considered to
change the electric, chemical, and biological properties
of cells, which can increase cell transfection efficiency.
We wanted to analyze possible underlying mechanisms
by which a formulation increases cell transfection effi-
ciency. We used scanning electron microscopy (SEM) to
observe morphological changes in the ASCs in the pre-
sence of our cell formulations. We incubated the seeded
ASCs in DMEM, OptiMEM, and Pulsing Buffer. The
SEM images in Figure 4a lack the projected small white
dots near the nuclei (mitochondria), which were present
when cells were incubated in cell culture medium
DMEM. These projected mitochondria were absent in
cells incubated in OptiMem (buffer O) and Pulsing (buf-
fer P) (Figure 4). These results demonstrate the associa-
tion between the effective buffer for transfection and
mitochondria projection.
Effects of pluronic-block copolymers on hMSCs
Of the pluronic-block copolymers, LMP1 showed the
greatest increase in transfection efficiency for ASCs of
murine origin [10]. We tested the effectiveness of pluro-
nic-block copolymers on hMSCs, which are phenotypically
similar to hASCs [12]. We compared various pluronic-
block copolymers that were previously optimized for both
hASCs and murine ASCs, along with Buffer O (Figure 5a),
Figure 2 Comparison of increase in transfection from polymers
from pluronic family for human adipose-derived stem cells
(ASCs). Error bars expressed as mean × SEM (n = 3). *, indicating a
significant difference was detected at p < 0.05. The key for polymer
abbreviations can be found in the Methods section. Cells were
nucleofected with program X-01, as determined in the first step.
Figure 3 Comparison of percentage of adipose-derived stem
cells (ASCs) positive for green fluorescent protein, as measured
by FACS. Cells treated with Amaxa nucleofector solution were
nucleofected with program U-23. All other cells were nucleofected
with program X-01, as determined in the first step. Bar indicates
mean transfection efficiency.
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We found that LMP5 yielded the same increase in trans-
fection efficiency-40% from the base efficiency of 30%-in
hMSCs as in hASCs (Figure 5b).
Comparison of transfection efficiencies
Our goal was to increase the rate of transfection of
hASCs and hMSC. We sought to increase efficiency
through modification of the formulation. With use of
pluronic-block copolymers in combination with optimal
buffers, we were able to successfully increase transfec-
tion efficiency up to 40%, which successfully outper-
formed the Amaxa buffer (32%) in our experiments
(Figure 3). This number is much lower than the 73%
[11] achieved in hMSCs when Amaxa buffers were used
by others. However, the 73% may have been overstated
[13].
Another study [14], which used the Amaxa MSC
nucleofector solution, claimed a 40%-60% transfection
rate with hASCs. However, it should be noted that, in
the previously mentioned study, the transfection rate
was determined through a count of fluorescent cells ver-
sus cells present in bright field imaging [14]. Our data
showed that analysis by flow cytometry provides a more
accurate representation of the true rate of transfection.
Zaragosi provides the best comparison, with 24-hour
transfection rates at 54.7% [15].
The main purpose of this study was to develop a sim-
ple and publicly known cell formulation that would
replace the secret Amaxa buffer for efficient transfection
of hASCs and hMSCs. We sought to accomplish this
through the use of known buffers in combination with
polymers. As observed in previous studies [10], the
pluronic-block copolymer family shows the most consis-
tent promise of boosting transfection efficiency. Pluro-
nic-block copolymers, which are composed of an
internal polyoxypropylene (hydrophobic) chain bordered
by external polyoxyethylene (hydrophilic) chains, have
been previously shown to have some use in gene ther-
apy [16]. The most notable observation was evidence
that different species of the pluronic-block copolymer
family provide the optimal boost in nucleofector effi-
ciency specific to each cell line. The variation of species
within this group is determined by two factors: the ratio
of hydrophobic to hydrophilic chains and the total
molecular weight of the species [16].
In our previous study, we determined LMP1 to have a
greater effect on transfection efficiency than LMP8 for
murine ASCs. This study illustrates that LMP5 is more
effective than LMP1 or LMP8 for two independent
types of human stem cells. The LMP1 species has both
a lower molecular weight and a lower hydrophile-to-
hydrophobe ratio than does LMP8. The LMP5 species
has a hydrophile-to-hydrophobe ratio more similar to
LMP8 and a similar molecular weight to LMP1 (~2
KDa). The effectiveness of LMP5, but not of LMP8 or
LMP1, suggests that both molecular weight and polari-
zation are critical for effectively transfecting human cells
via nucleofection.
Potential mechanism of transfection
The mechanism of electroporation is not well under-
stood. The current thought is that electroporation
Figure 4 Scanning electron micrograph of human adipose-
derived stem cells (hASCs).( a) hASCs in DMEM cell culture
medium. (b) hASCs in buffer O. (c) hASCs in buffer P.
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large molecules to enter the cytosol through simple dif-
fusion [17,18]. Originally, polymers in solution were
believed to bind to DNA and assist in transport across
the membrane [19]. However, we showed in earlier stu-
dies that the addition of pluronic-block copolymers
offered no difference in transfection effectiveness when
first combined with cells or with DNA [10]. It is worth
noting that the increase in transfection results from the
influence of the pluronic molecules on the cell itself. In
our previous study, we looked at morphologic changes
to the overall structure of the cell in different buffer
conditions. Using SEM, we found that the nucleus of
the cell projected more toward the plasma membrane,
which offers a possibility for the transport of macromo-
lecules directly into the nucleus [10]. For hASCs, we did
not observe the same nuclear projection that was noted
with murine ASCs. Instead, we noted an increase in
mitochondrial activity around the nuclear region, sug-
gesting that the mitochondria play a role in boosting
DNA transfection. This should be further explored in
future studies.
Conclusion
hASCs and hMSCs have a similar phenotype [5,12], so
polymers that boost transfection efficiency of one cell
type should produce a similar boost in the other. Our
initial comparison of pluronic-block copolymers in
hMSCs shows that the same concentration of LMP5
produces the same increase in transfection efficiency in
both cell types. This suggests that the same mechanism
is at work to boost transfection efficiency for human
stem cell lines. Further study is needed to understand
this relationship and to determine whether any other
cell types that are boosted in this fashion.
Methods
Cell culture
The hASCs were isolated from human adipose tissue by
collagenase digestion and culture expansion in DMEM/
F12 Ham’s Medium, 10% FBS, 1% antibiotic/antimycotic
according to published methods [4]. Isolation of adi-
pose-derived adult stem cells from human liposuction
aspirates and surgically excised adipose depots was
approved by Pennington Biomedical Reearch Center,
Louisiana State University system with IRB number
23040.
Buffers and polymers
OptiMEM (Buffer O) is a commercial buffer that was
purchased from Invitrogen (Carlsbad, CA) and stored at
4°C. Pulsing buffer (Buffer P), consisting of 125 mM
Figure 5 Efficiency of cellular transfection of human mesenchymal stem cells (MSCs) between Buffer O and two pluronic-block
copolymers.( a) Chemical composition of modifiers used for in part b.( b) Detection of green fluorescent protein (GFP)-positive cells using
FACS, with percentage of hASCs positive for expression of GFP.
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1.2 mM MgCl2 (pH7.4), is made from a 10× homemade
stock solution, filtered, and stored at 4°C. After prepara-
tion, the solution is filtered through a 0.2-μm filter and
stored at room temperature.
LMA1 stock was made to a 10% (wt/vol) of Poly-L-
glutamic acid (mw 15-50 kDa, Sigma-Aldrich, St Louis,
MO) in MQ-H2O. LME1 (polyethylene glycol, mw 8
kDa, Amresco, Solon, OH), LMP8 (poloxamer 188, mw
8 kDa, Spectrum Chemicals, New Brunswick, NJ), LMP1
(poloxamer 181, mw 2 kDa, Spectrum Chemicals),
LMP5 (poloxamer 95, mw 1.8 kDa, Sigma-Aldrich), and
LMV1 (polyvinylpyrrolidone, mw 40 kDa, Fisher Scienti-
fic, Pittsburg, PA) stocks were all made to 20% (wt/vol)
in MQ-H2O. LMP3 (Pop313, donated from Expression
Genetics, Huntsville, AL) was made to a stock concen-
tration of 0.01% (wt/vol) in MQ-H2O. All stock buffers
were stored at 4°C and were kept for 1 month.
Electroporation of plasmid DNA
Cells were pelleted and resuspended in 100 μL transfec-
tion buffer at a concentration of 1.0 × 10
6 cells/100 μL
and then transferred to a sterile 3-mm Amaxa nucleo-
fection cuvette. Cells were incubated with 2 μgr e p o r t e r
gene encoding plasmid DNA. The reporter genes, GFP
(green florescence protein) and luciferase, were driven
by CMV promoter at the 5’-end and terminated by the
human growth hormone polyadenylation signal at the 3’
e n d .T h es i z eo fG F Pa n dl u c iferase plasmid DNA are
4.7 and 4.3 kb, respectly. Cells were electroporated with
use of the appropriate nucleofection program. Nucleo-
fected cells were then rinsed with 500 μL of sterile cul-
ture medium and transferred to the well of a sterile 12-
well plate. Cells were incubated at 37°C for 24 hours
before analysis.
Flow cytometry
For flow cytometry analysis, GFP plasmid DNA was
transfected into the targeted cells using the indicated
formulation. GFP positive cells (% of total cells) were
detected using flow cytometry. Before flow cytometry
was performed, cells were harvested by trypsinization
and resuspended in 1000 μLo fP B S .S o m eo ft h ec e l l
suspension (500 μL) was removed and fixed in PBS +
1.0% formaldehyde solution before analysis. Cells were
measured by a BD FACSCalibur (BD Biosciences; San
Diego, CA).
Luciferase and protein assays
After incubation, cells were lysed and assayed for luci-
ferase activity (Cell lysis kit, Promega; Madison, WI;
part# E4030). Briefly, cell pellets were rinsed with PBS
and lysed with 200 μL of lysis reagent with use of the
freeze-thaw method. Cell lysates were kept at 4°C during
analysis and stored at -20°C when not in use. Next, 20
μL of cell lysates (after spining) were transferred to a
96-well plate. Luciferase activity was measured by using
a Packard LumiCount (Perkin Elmer; Boston, MA). All
luciferase activity was normalized to the protein with
use of the following equation: [(luciferase activity in
RLU) × 200]/(per μg protein).
Protein assays were conducted by using a commer-
cially purchased BCA protein assay kit (Thermo Scienti-
fic; Rockford, IL; Product # 23227). Briefly, 4 μL of cell
lysate prepared from luciferase assay was transferred to
a clear 96-well plate. Protein levels were measured by a
Packard SpectraCount (Perkin Elmer). Protein assay
measurements were calibrated to a BSA standard with a
maximum of 40 μg and analyzed by I-Smart 2.0 (Perkin
Elmer).
Electron microscopy
5×1 0
4 hASCs were seeded onto 13-mm round Ther-
manox cover slips (Thermo Fisher Scientific, Rochester,
NY) placed in a sterile 24-well plate. Cells were grown
until they reach 40%-50% confluence. All growth med-
ium was removed from the wells, and cells were incu-
bated at room temperature for 10 minutes in one of the
following solutions before processing for SEM: DMEM,
Buffer O, Buffer P, and 1/2 saline nucleofector solution.
Briefly, cells were fixed in 1.25% glutaraldehyde and 2%
formaldehyde in 0.1 M sodium cacodylate (CAC) buffer
for 1 hour at room temperature. Cells were then washed
in 0.1 M CAC buffer, treated with 1% osmium tetroxide
in 0.1 M CAC, and washed again. Cells were then dehy-
drated in ethanol before platinum-coating.
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